1[1]IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Helicobacter pylori[M].In "Schistosomes,Liver Flukes and Helicobacter pylori:Views and Export Opinions of an IARC Working Group on the Evaluation of Carcinogenic R isks to Humans”,IARC,Lyon.1994,177(1994).
2[2]CVI News[N],1999,1:9.
3[3]Czinn SJ,Nedrud JG.Oral immunization against Helicobacter pylori[J] .Infect Immun, 1991,59(7):2359.
4[4]Ikewaki J,Nishizono A,Goto T,et al.Therapeutic oral vaccination induc es mucosal immune response sufficient to eliminate long-term Helicobact er pylori infection[J]. Microbiol Immunol,2000,44(1):29.
5[5]Michetti P,Corthesy TI,Davin C,et al.Immunization of BALB/c mice agai nst Helicobacter felis infection with Helicobacter pylori urease[J].J Gastroen terology,1994,107(4):1002.
6[6]CKleanthous H,Myers GA,Georgakopoulos KM,et al.Rectal and intranasal immuni zations with recombinant urease induce distinct local and serum immune responses in mice and protect against Helicobacter pylori infection[J]. Infect Immun,1998,66(6):2879.
7[7]Weltzin R,Guy B,Thomas wo,et al.Parenteral adjuvant activities of Esc herichia coli heat-labile toxin and its B subunit for immunization of mice again st gastric Helicobacter pylori infection[J].Infect Immun,2000, 68(5):2775.
8[8]Gomez Duarte OG,Bumann D,Meyer TF.The attenuated Salmonella vaccine approach for the control of Helicobacter pylori-related disease s[J].Vaccine,1999,17(13～14):1667.
9[9]Lee CK,Soike K,Hill J,et al.Immunization with recombinant Helicobacte r pylori urease decreases colonization levels following experimental inf ection of rhesus monkeys[J].Vaccine,1999,17(11～12):1493.
10[10]Solnick JV,Canfield DR,Hansen LM,et al.Immunization with recombinant Helicobacter pylori urease in specific-pathogen-free rhesus mon keys (Macaca mulatta)[J].Infect Immun,2000,68(5):2560.
4Doidge C Crust Ⅰ Lee A et al.Therapeutic immunisation against Helicobacter infection[J].Lancet,1994,343:914-915.
5Richard AA, James B, Beth M, et al. Comparative genomics of Helicobacter pylori : andlysis of the outer membrane protein families. Infection and Immunity,2000,68(7) :4155-4168.
6Magdalena K, Paul WO, Diane ET, et al. Molecular characterzation of a conserved 20-kilodalton membrane-associated lipoprotein antigen of Helicobacter pymlori .J of Bacteriology, 1994,176(9) :5938-5948.
7Jacqueline K, Jane O, Neil D, et al. Immune response to an 18-kilodalton outer membrane antigen identifies lipoprotein 20 as a Helicobacter pylori vaccine candidate. Infect Immun, 2000,68 (6) : 3337-3343.
8Shiesh SC, Sheu BS, Yang HB, et al. Serologic response to lower molecular-weight proteins of Helocobacter pymori is related to clinical outcome of Helocobacter pymori infection in Taiwas. Dig Dis Sci,2000,45:781-788.
9Konturek PC, Konturek SJ, Starlyska T, et al. Helicobacter pymori-gastric link in MALT lymphoma. Aliment Pharmacol Ther,2000,14:1311-1318.
